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During this third reporting year (5/15/88 to 1 5/14/89), the followip~g drugs were tested for their immunornodulatory actions: -Acridine trihydrochloride (CL246), 0K432, WY18251, poly !Ct C (AVS1761), Qunoiriarnine ;(AVS:_1300), and Ampli-:-.-(AVS2149). These drugs were tested for their effects on the production of adtibody that is ttimulated upon addition of Pokeweed Mitogen (PWM) to lymphocyte cultures or upon infection of lymphocytes with Epstein-Barr Virus (EBV). The drugs were also tested for their effects on lymphocyte proliferation stimulated by EBV. Finall, the drugs were tested for their ability to modulate the generation of lymphokine activated killer cells (LAK) which are stimulated upon culturing T lymphocytes with Interleukin 2 (1L2). We found that Acridine trihydrochloride had a pronounced inhibitory effect on all of the above tested functions. This inhibition was most pronounced with drug concentrations above 0.t../ml. Quinolinamine at concentrations above 0.1 js.,/ml stimulated both the PWM-stimulated 1gM and IgG production , as well as the EBV-induced proliferation of lymphocytes. This drughtad also a small, but significaM augmenting effect on EPVinduced .lgM production at >1 lt.iml without, however, Offecting the virus-induced lgG oroductioni. Finally, at low cone IentrptIons (0.001-1 rig/mI) Quiolinamine stimulated the induction of LAK cells while at higher concentrations (2.5-20 m)inhibited their production. From the rest of the drugs poly ICLC inhibited the EBV-stimulated production of 1gM ani dy and the generation of LAK cells, WY18251 and 0K432 had a small inhibitory effect on EBV-stimulated 1gM prodpYction and the rest of the drugs Acridine trihydrochloride (CL246), OK432, WY18251, poly ICLC (AVSI761), Quinolinamino (AVSI300), and Ampligen (AVS2149) . These drugs were tested for their effects on the production of antibody that is stimulated upon addition of Pokeweed Mitogen (PWM) to lymphocyte cultures or upon infection of lymphccytes with Epstein-Barr Virus (EBV) . The drugs were also tested for their effects on lymphocyte proliferation stimulated by EBV.
Finally, the drugs were tested for their ability to modulate the generation of lymphokine activated killer cells (LAK) which are stimulated upon culturing T lymphocytes with Interleukin 2 (IL2).
In order to study effects on mitogen-stimulated antibody production, we employed the Pokeweed Mitogen (PWM)-driven system where peripheral blood lymphocytes are stimulated in vitro and the produced antibody is measured in the tissue culture supernatant by ELISA. In particular, duplicate 12x75 mm tissue culture tubes containing Ixl0 6 peripheral blood lymphocytes in 1 ml of RPMI 1640-10% FCS and an optimal amount of PWM (in our experiments 0.1 Vg/ml) are incubated for 9 days in a humidified atmosphere of 95% air-5% C02 at 370C. The culture supernatants are collected, cleared of any cells by centrifugation and their IgM and IgG antibody content tested by ELISA.
In the ELISA assay duplicate microtiter plate wells are pre-coated with either goat anti-human IgM or IgG (1 g/ml), the samples are added and then developed with a pre-determined optimal concentration of Alkaline Phosphatase (AP)-conjugated goat anti-human IgM or IgG respectively in the presence of substrate.
The amount of antibody in each sample is then quantified by assessing the amount of colored end-product by optical density scanning of the plate at 405 nm.
To test the effects of the drugs, peripheral blood lymphocytes were incubated with various concentrations of each drug and 0.1 g/ml PWM or medium as a control. The secreted IgM and IgG was then quantified by ELISA.
The results shown in Figure 1 are representative of four experiments using different blood donors.
It can be seen that Acridine trihydrochloride has a dose dependent suppressive effect for both antibody isotypes.
In contrast, Quinolinamine had a stimulatory effect for IgM and IgG. The rest of the drugs had no significant effects on antibody production as tested in this system. None of the drugs had toxic effects in the concentration range t-t-d.
In the above experiments, PWM induces an antibody response which is dependent on the participation of T cells thus, any effects of the drugs could be interpreted either as effects on T or B lymphocytes.
In the experiments described in this section the use of EBV addresses this question. EBV is a specific B lymphotropic virus which infects B cells and causes their proliferation and production of antibody. Thus, any effects of the druqs in the EBV system must be directed specifically to the B cell itself.
In this system, human peripheral blood lymphocytes are purified by removing T cells with sheep red blood cell rosetting and monocytes by adherence on plastic dishes. This gives a population of B cells which is >90% surface Ig+ and contains <1% T cells.
The rest of the cells in the population are residual monocytes and some natural killer cells.
This degree of purity is sufficient for the studies, considering that EBV specifically infects B cells only. The B cells are placed in culture dishes and incubated in the presence of an optimal viral dose and various drug concentrations.
Appropriate positive and negative controls are also included. After an appropriate incubation period cellular proliferation is assessed and the production of antibody released in the culture supernatant is quantified by ELISA.
When the effects on EBV-induced proliferation \ , assessed, we found that Acridine trihydrochloride was inhibitory at concentration--', 5vg/ml while Quinolinamine was stimulatory at concentrations >0.1 Vg/ml (Figure 2 .
As for the effects on the EBVinduced antibody production, Acridine trihydrochloriae again displayed a suppressivP effect at similar concentrations while Quinolinamine stimulated only the IgM response, but not the IgG response (Figure 3 ).
WY18251 and OK432 had a slight inhibitory effect on the IgM production. (Figure 3) .
The rest of the drugs had no detectable effects at the concentrations tested.
The results with Acridine trihydrochloride and Quinolinamine are very consistent with chose obtained with PWM, suggesting that the effects of these drugs are directed against B lymphocytes. Cultures were incubated for 8 days and proliferation was assessed by addition of 3[H]-thymidine (1 pCi/well) during the last 5 hours of incubation.
The "*" indicates the positive control with EBV without any drug and the "o" indicates the negative control with only medium. The results are expressed as average CPM of triplicate cultures versus drug concentration.
The standard deviation of replicate points was <10% of the average.
The results are typical of four separate experiments using different donors.
Legend to Figure 3 Effects of Drugs on Lhw EBV-induced jgm and lgG production by B ivympncyres:
Peripheral B lymphocytes were isolated as described in the legend of the figure above and cultured at Ix,0 6 cells per well per ml with or without EBV (1:5 dilution of vixuscontaining supernatant) in the presence of various drug concentrations as indicated above. After 14 days of culture the cells were removed and the supernatants were assayed for the presence of IgM and IgG using a solid phase ELISA assay described in the text above.
The
indicates the positive control with EBV without any drug and the "o" indicates the negative control with only medium. The results are expressed as average O.D. at 405 nm of duplicate determinations versus drug concentration.
The standard deviation of replicate points was <5% of the average. The results are typical of four separate experime.,ts using different donors. The L.U. per culture were calculated from the total number of viable LAX cells recovered in each culture.
The cell viability in all cultures ranged from 80-95%.
The (0) represen-t the control culture without any drug.
